comparemela.com
Home
Live Updates
Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA) : comparemela.com
Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA)
EQS-News: Formycon AG
/ Key word: Regulatory Admission/Miscellaneous
Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 , by the U.S....
Related Keywords
Munich ,
Bayern ,
Germany ,
Canada ,
Japan ,
Australia ,
Stefan Glombitza ,
Klinge Biopharma Gmbh ,
Drug Administration ,
Trademark Of Regeneron Pharmaceuticals Inc ,
Corporate Communications ,
Press Release ,
File Acceptance ,
Active Ingredient ,
Regeneron Pharmaceuticals ,
Manager Corporate Communications ,
Markets ,
comparemela.com © 2020. All Rights Reserved.